NBC Securities’s Inhibrx INBX Stock Holding History

NBC Securities’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$255K	Buy	3,800 +800	+27%	+$59.3K	0.02%	760
2025 Q4	$237K	Hold	3,000	–	–	0.02%	781
2025 Q3	$101K	Buy	+3,000	New	+$73.9K	0.01%	1068

Other funds holding INBX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NBC Securities's INBX Position: Q1 2026 in Review

NBC Securities increased its Inhibrx (INBX) stake by 27% in Q1 2026, buying an estimated $59.3K and bringing the position to 3,800 shares worth $255K. The position accounts for 0.02% of the portfolio, ranked #760.

NBC Securities first reported a position in INBX in Q3 2025 and has held it in 3 quarters since. 135 funds tracked by Wall St. Rank hold INBX as of Q1 2026.

NBC Securities held 3,800 shares of Inhibrx worth $255K as of Q1 2026.
NBC Securities bought 800 Inhibrx shares in Q1 2026, an estimated $59.3K.
Inhibrx made up 0.02% of NBC Securities's portfolio in Q1 2026, its #760 holding.
NBC Securities first reported a position in Inhibrx in Q3 2025 and has held it in 3 quarters since.
135 funds tracked by Wall St. Rank held Inhibrx as of Q1 2026.

Based on NBC Securities's 13F filing for Q1 2026, filed 14 Apr 2026.